vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $223.8M, roughly 1.2× SILVERCORP METALS INC). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -1.3%, a 2.0% gap on every dollar of revenue.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.
HCM vs SVM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $223.8M |
| Net Profit | $2.0M | $-2.9M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | -1.3% |
| Revenue YoY | -16.5% | — |
| Net Profit YoY | -83.6% | — |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $223.8M | ||
| Q2 25 | $277.7M | $72.2M | ||
| Q1 25 | $324.5M | — | ||
| Q4 24 | — | $172.5M | ||
| Q3 24 | — | $114.0M | ||
| Q2 24 | $305.7M | $60.0M | ||
| Q4 23 | — | $174.0M | ||
| Q3 23 | — | $115.3M |
| Q4 25 | $2.0M | $-2.9M | ||
| Q2 25 | $455.0M | $28.1M | ||
| Q1 25 | $11.9M | — | ||
| Q4 24 | — | $42.1M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | $25.8M | $13.2M | ||
| Q4 23 | — | $18.8M | ||
| Q3 23 | — | $3.9M |
| Q4 25 | 37.7% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | -13.2% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q4 24 | — | 30.5% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | -9.0% | 30.0% | ||
| Q4 23 | — | 16.8% | ||
| Q3 23 | — | 10.4% |
| Q4 25 | 0.7% | -1.3% | ||
| Q2 25 | 163.8% | 39.0% | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | — | 24.4% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | 8.4% | 22.0% | ||
| Q4 23 | — | 10.8% | ||
| Q3 23 | — | 3.4% |
| Q4 25 | $0.00 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.03 | — | ||
| Q4 23 | — | $0.11 | ||
| Q3 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $1.8B | — |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $93.2M | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $759.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $740.1M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.3B | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | 0.08× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $107.9M |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $107.9M | ||
| Q2 25 | $-72.9M | $40.0M | ||
| Q1 25 | $40.3M | — | ||
| Q4 24 | — | $81.3M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | $-39.8M | $28.9M | ||
| Q4 23 | — | $79.9M | ||
| Q3 23 | — | $54.2M |
| Q4 25 | $3.4M | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $33.8M | ||
| Q2 24 | $-49.9M | $17.0M | ||
| Q4 23 | — | $45.7M | ||
| Q3 23 | — | $31.5M |
| Q4 25 | 1.2% | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | -16.3% | 28.3% | ||
| Q4 23 | — | 26.2% | ||
| Q3 23 | — | 27.3% |
| Q4 25 | 1.8% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | 3.3% | 19.8% | ||
| Q4 23 | — | 19.7% | ||
| Q3 23 | — | 19.7% |
| Q4 25 | 4.21× | — | ||
| Q2 25 | -0.16× | 1.42× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | -1.54× | 2.19× | ||
| Q4 23 | — | 4.25× | ||
| Q3 23 | — | 13.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
